Authors:
RUND D
DAGAN M
DALYOTHERMAN N
KIMCHISARFATY C
SCHOENLEIN PV
GOTTESMAN MM
OPPENHEIM A
Citation: D. Rund et al., EFFICIENT TRANSDUCTION OF HUMAN HEMATOPOIETIC-CELLS WITH THE HUMAN MULTIDRUG-RESISTANCE GENE-1 VIA SV40 PSEUDOVIRIONS, Human gene therapy, 9(5), 1998, pp. 649-657
Authors:
STEINER H
POLLIACK A
KIMCHISARFATY C
LIBSTER D
FIBACH E
RUND D
Citation: H. Steiner et al., DIFFERENCES IN RHODAMINE-123 EFFLUX IN B-TYPE CHRONIC LYMPHOCYTIC-LEUKEMIA SUGGEST POSSIBLE GENDER AND STAGE VARIATIONS IN DRUG-RESISTANCE GENE ACTIVITY, Annals of hematology, 76(5), 1998, pp. 189-194
Citation: V. Oronkarni et al., RAPID DETECTION OF THE COMMON MEDITERRANEAN ALPHA-GLOBIN DELETIONS REARRANGEMENTS USING PCR/, American journal of hematology, 58(4), 1998, pp. 306-310
Authors:
RUND D
BENNERIAH S
YEHUDA O
LEIZEROWITZ R
OKON E
POLLIACK A
Citation: D. Rund et al., DE-NOVO ACUTE MYELOID-LEUKEMIA WITH NEAR-PENTAPLOIDY - DIPLOID KARYOTYPE AND LYMPHOBLASTIC PHENOTYPE AT RELAPSE, Leukemia & lymphoma, 25(5-6), 1997, pp. 585-591
Citation: V. Oronkarni et al., A NOVEL MECHANISM GENERATING SHORT DELETION INSERTIONS FOLLOWING SLIPPAGE IS SUGGESTED BY A MUTATION IN THE HUMAN ALPHA(2)-GLOBIN GENE/, Human molecular genetics, 6(6), 1997, pp. 881-885
Citation: D. Rund et al., INTENSIVE PLASMAPHERESIS FOR SEVERE THROMBOTIC THROMBOCYTOPENIC PURPURA - LONG-TERM CLINICAL OUTCOME, Journal of clinical apheresis, 12(4), 1997, pp. 194-195
Authors:
RUND D
ORONKARNI V
FILON D
GOLDFARB A
RACHMILEWITZ E
OPPENHEIM A
Citation: D. Rund et al., GENETIC-ANALYSIS OF BETA-THALASSEMIA-INTERMEDIA IN ISRAEL - DIVERSITYOF MECHANISMS AND UNPREDICTABILITY OF PHENOTYPE, American journal of hematology, 54(1), 1997, pp. 16-22
Citation: V. Oronkarni et al., RAPID DETECTION OF THE COMMON MEDITERRANEAN ALPHA-GLOBIN DELETIONS REARRANGEMENTS USING PCR/, Blood, 90(10), 1997, pp. 2853-2853
Citation: H. Steiner et al., GENDER DIFFERENCES IN MULTIDRUG-RESISTANCE GENE-1 (MDR1) EXPRESSION IN LOW-GRADE, B-CELL TYPE NONHODGKINS-LYMPHOMA (NHL), Blood, 90(10), 1997, pp. 3659-3659
Citation: D. Rund et al., A MUTATION IN THE PROMOTER OF THE MULTIDRUG-RESISTANCE GENE (MDR1) INHUMAN HEMATOLOGICAL MALIGNANCIES MAY CONTRIBUTE TO THE PATHOGENESIS OF RESISTANT DISEASE, Blood, 90(10), 1997, pp. 803-803
Authors:
ORONKARNI V
FILON D
RUND D
RACHMILEWITZ E
OPPENHEIM A
Citation: V. Oronkarni et al., PRENATAL-DIAGNOSIS BASED ON SIMULTANEOUS DNA ANALYSIS FOR ALPHA-GLOBIN AND BETA-GLOBIN GENES, American journal of hematology, 53(3), 1996, pp. 203-204
Citation: S. Gillis et al., SELECTIVE DISCHARGE OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA DURING CHEMOTHERAPY-INDUCED NEUTROPENIA, American journal of hematology, 51(1), 1996, pp. 26-31
Authors:
BENYEHUDA D
KRICHEVSKY S
CASPI O
RUND D
POLLIACK A
ABELIOVICH D
ZELIG O
YAHALOM V
PALTIEL O
OR R
PERETZ T
BENNERIAH S
YEHUDA O
RACHMILEWITZ EA
Citation: D. Benyehuda et al., MICROSATELLITE INSTABILITY AND P53 MUTATIONS IN THERAPY-RELATED LEUKEMIA SUGGEST MUTATOR PHENOTYPE, Blood, 88(11), 1996, pp. 4296-4303
Citation: H. Steiner et al., ARE THERE GENDER DIFFERENCES IN MULTIDRUG-RESISTANCE GENE-I (MDR1) EXPRESSION IN CHRONIC LYMPHATIC-LEUKEMIA (CLL), Blood, 88(10), 1996, pp. 951-951
Authors:
BENYEHUDA D
KRICHEVSKY S
CASPI O
RUND D
POLLIACK A
ZELIG O
YAHALOM V
PALTIEL O
OR R
RACHMILEWITZ EA
Citation: D. Benyehuda et al., MICROSATELLITE INSTABILITY AND P53 MUTATIONS IN THERAPY-RELATED LEUKEMIA SUGGESTS MUTATOR PHENOTYPE, Blood, 88(10), 1996, pp. 2222-2222
Citation: D. Rund et E. Rachmilewitz, ADVANCES IN THE PATHOPHYSIOLOGY AND TREATMENT OF THALASSEMIA, Critical reviews in oncology/hematology, 20(3), 1995, pp. 237-254
Authors:
CASPI O
KRICHEVSKY S
RUND D
ABELIOVICH D
ZELIG O
POLLIACK A
PALTIEL O
RACHMILEWITZ EA
BENYEHUDA D
Citation: O. Caspi et al., MOLECULAR ANALYSIS OF SECONDARY LEUKEMIAS - MUTATOR PHENOTYPE AS THE CAUSE OF DIFFERENT P53 MUTATIONS IN MULTIPLE MALIGNANCIES IN THE SAME INDIVIDUAL, Blood, 86(10), 1995, pp. 656-656